Renalytix Plc (RNLXY)
3.39
-0.11
(-3.14%)
USD |
OTCM |
Oct 15, 16:00
Renalytix Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | -9.973M |
| September 30, 2024 | -3.836M |
| June 30, 2024 | -7.826M |
| March 31, 2024 | -4.862M |
| December 31, 2023 | -7.919M |
| September 30, 2023 | -9.504M |
| June 30, 2023 | -8.633M |
| Date | Value |
|---|---|
| March 31, 2023 | -10.10M |
| December 31, 2022 | -8.232M |
| September 30, 2022 | -7.119M |
| June 30, 2022 | -14.17M |
| March 31, 2022 | -7.023M |
| December 31, 2021 | -14.24M |
| September 30, 2021 | -10.49M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| CompuMed, Inc. | 0.4229M |
| Quest Diagnostics, Inc. | 597.00M |
| Labcorp Holdings, Inc. | 445.50M |
| Myriad Genetics, Inc. | -8.30M |
| OPKO Health, Inc. | -43.50M |